InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,695.94
(
-0.96%
)
US TECH 100
19,272.14
(
-1.13%
)
Dow Jones
41,954.24
(
-0.94%
)
Brent Oil
79.60
(
-1.66%
)
Bitcoin
62,744.14
(
0.84%
)
Post# of 660558
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TraderUsa

Send PM Follow Ignore
Followers 79
Posts 7854
Boards Moderated 2
Alias Born 05/05/2011

TraderUsa

Re: TraderUsa post# 245232

Friday, 01/25/2013 6:49:19 AM

Friday, January 25, 2013 6:49:19 AM

Post# of 660558
$ZLCS Strong News! Covidien (COV) report STRONG SALES of Exalgo (more royalties for Zalicus):

"Pharmaceuticals sales of $489 million in the first quarter were essentially unchanged from last year’s first-quarter sales of $490 million. Sales of Specialty Pharmaceuticals climbed sharply from those of a year ago, primarily due to the strong performance of EXALGO® (hydromorphone HCl) ER tablets and good growth for generic products that was aided by the launch of generic"

http://finance.yahoo.com/news/covidien-reports-first-quarter-results-110000493.html

Is my humble opinion.

Do not forget to go through this ihub :
http://investorshub.advfn.com/boards/board.aspx?board_id=20991

$$ DEVALUED STOCKS $$

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up